Several thousand people have added their names to the sign-on letter at www.malecare.com, in just the first week. With May 31 as our dead line, many more names will be added. Our prostate cancer community is showing its size and cohesion. As Lance Armstrong so brilliantly advocates, we are living strong. We've also received about [...]
Treatments for all cancers, including prostate cancer, have improved over the last ten years. As treatments improve, we have created a growing population of cancer survivors. Neither our hospitals, doctors nor our society has acknowledged this exploding population. We have failed to provide any support system for these survivors, their caregivers or their families. Left [...]
Spectrum Pharmaceuticals announces that the FDA's Oncology Drug Advisory Committee (ODAC) will review their very promising investigational drug Satraplatin for the Treatment of Hormone Refractory Prostate Cancer. The hearing will be held on July 24, 2007. This is very exciting, especially in light of the FDA’s surprising failure to approve Provenge. A quick review of [...]
In today’s Wall Street Journal there is a fantastic opinion piece written by Dr. Mark Thornton, Black Wednesday at the FDA. Dr. Thornton points out that not only did the FDA not approve Provenge last Wednesday, but also it failed to approve Junovan, a immunological drug designed to treat young children with a rare bone [...]
There is a sign on action letter to the FDA regarding it's CR letter on Provenge, at www.malecare.com Please take a look and if you agree, sign on. Also, please help get the word out about this, as we will mail this letter and its signatories on May 18, 2007.